Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Insulin-like growth factor 1 receptor | ||
Ligand | BDBM50375340 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_471114 (CHEMBL921267) | ||
IC50 | 130±n/a nM | ||
Citation | Mulvihill, MJ; Ji, QS; Coate, HR; Cooke, A; Dong, H; Feng, L; Foreman, K; Rosenfeld-Franklin, M; Honda, A; Mak, G; Mulvihill, KM; Nigro, AI; O'Connor, M; Pirrit, C; Steinig, AG; Siu, K; Stolz, KM; Sun, Y; Tavares, PA; Yao, Y; Gibson, NW Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors. Bioorg Med Chem16:1359-75 (2008) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Insulin-like growth factor 1 receptor | |||
Name: | Insulin-like growth factor 1 receptor | ||
Synonyms: | CD_antigen=CD221 | IGF-I receptor | IGF1R | IGF1R_HUMAN | Insulin-like growth factor 1 receptor (IGF1R) | Insulin-like growth factor 1 receptor (IGFIR) | Insulin-like growth factor 1 receptor alpha chain | Insulin-like growth factor 1 receptor beta chain | Insulin-like growth factor I receptor | Insulin-like growth factor receptor (IGFR) | ||
Type: | Protein | ||
Mol. Mass.: | 154776.79 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08069 | ||
Residue: | 1367 | ||
Sequence: |
| ||
BDBM50375340 | |||
n/a | |||
Name | BDBM50375340 | ||
Synonyms: | CHEMBL258951 | ||
Type | Small organic molecule | ||
Emp. Form. | C29H28N6S | ||
Mol. Mass. | 492.638 | ||
SMILES | Nc1nccn2c(nc(-c3ccc4ccc(nc4c3)-c3ccccc3)c12)[C@@H]1C[C@@H](C1)N1CCSCC1 |wU:26.30,28.35,(-8.5,-13.48,;-8.49,-15.02,;-9.82,-15.79,;-9.82,-17.34,;-8.49,-18.11,;-7.15,-17.34,;-5.67,-17.82,;-4.76,-16.56,;-5.68,-15.31,;-4.9,-13.98,;-5.66,-12.65,;-4.89,-11.32,;-3.34,-11.32,;-2.58,-9.99,;-1.03,-10,;-.25,-11.34,;-1.03,-12.67,;-2.58,-12.67,;-3.36,-13.99,;1.28,-11.35,;2.05,-12.68,;3.59,-12.68,;4.36,-11.35,;3.59,-10.01,;2.05,-10.02,;-7.15,-15.79,;-5.2,-19.28,;-5.89,-20.65,;-4.52,-21.35,;-3.82,-19.98,;-4.04,-22.81,;-4.94,-24.06,;-4.31,-25.45,;-2.78,-25.6,;-1.88,-24.35,;-2.52,-22.95,)| | ||
Structure |